Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Molecule (Biologics and Small Molecules), Route of Administration (Intravenous and Oral), Target Disease Indication (Amyotrophic Lateral Sclerosis, Leptomeningeal Carcinomatosis, Mucopolysaccharidosis Type II (Hunter Syndrome), Mucopolysaccharidosis Type III A (Sanfilippo Syndrome A) and Multiple Sclerosis) and Therapeutic Area (Lysosomal Storage Disorders, Neurodegenerative Disorders and Neuro-Oncology Disorders) and Key Geographical Regions (North America, Europe and Asia-Pacific and Rest of the World)